With the analysis among 1,351 patents, we discovered top 449 key players by total patent application. Agensys, Inc., Seagen Inc., Alector, Inc. are dominant in this area. They take 18.95% of the total patent filing.
California, United States
Patent: 155
Washington, United States
Patent: 62
California, United States
Patent: 39
University Health Network
Ontario, Canada
Patent: 34
Basel-Stadt, Switzerland
Patent: 21
California, United States
Patent: 21
Massachusetts, United States
Patent: 17
Tokyo-to, Japan
Patent: 16
Chugai Pharmaceutical Co., Ltd.
Tokyo-to, Japan
Patent: 15
F. Hoffmann-La Roche Ltd.
With the analysis among 56 patents, we discovered top 12 start-ups by total patent application. Go Therapeutics, Inc., Hangzhou Sumgen Biotech Co., Ltd., ALX Oncology, Inc. are active in this area.
Massachusetts, United States
Patent: 17
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 12
California, United States
Patent: 8
Institut National de la Santé et de la Recherche Médicale
Bluefin Biomedicine, Inc.
Massachusetts, United States
Patent: 4
Massachusetts, United States
Patent: 4
Lansion Biotechnology Co. Ltd.
Jiangsu Sheng, China
Patent: 1
Alchemab Therapeutics Ltd.
KOTAI Biotechnologies, Inc.
Luxembourg, Belgium
Patent: 1
With the analysis among related 826 patents applied in the last 5 years. We discover 406 most active companies in this area. The fast-growing Alector, Inc., University of Florida, MedImmune Ltd. take 7.75% of patent filing during this period.
California, United States
Patent: 31
Cambridgeshire, United Kingdom
Patent: 14
Massachusetts, United States
Patent: 13
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 12
Sumgen Monoclonal Antibody (Beijing) Biotechnology Co Ltd
Beijing Shi, China
Patent: 11
Chinese Academy For Agricultural Sciences Lanzhou Veterinary R
Jiangsu Sheng, China
Patent: 10
Regeneron Pharmaceuticals, Inc.
New York, United States
Patent: 10
California, United States
Patent: 8
With the analysis among related 826 patents in last 5 years, we discover 326 new entrants. University of Florida, MedImmune Ltd., Hangzhou Sumgen Biotech Co., Ltd. are the most active new entrants in this area.
Cambridgeshire, United Kingdom
Patent: 14
Hangzhou Sumgen Biotech Co., Ltd.
Zhejiang Sheng, China
Patent: 12
Sumgen Monoclonal Antibody (Beijing) Biotechnology Co Ltd
Beijing Shi, China
Patent: 11
Sorrento Therapeutics, Inc.
California, United States
Patent: 8
California, United States
Patent: 7
Biobase Biodustry (Shandong) Co., Ltd.
Shandong Sheng, China
Patent: 6
Tianjin Era Biology Engineering Co. Ltd.
Tianjin Shi, China
Patent: 6
With the analysis among 509 patents, we discovered top 148 universities and scientific research institutions by total patent application. Hubei University of Technology, Yangzhou University, Zhejiang University are dominant in this area. They take 14.93% of the total patent filing.
Hubei University of Technology
Hubei Sheng, China
Patent: 11
Jiangsu Sheng, China
Patent: 11
Zhejiang Sheng, China
Patent: 9
Hunan Sheng, China
Patent: 9
Jilin Sheng, China
Patent: 8
Zhejiang Sci-Tech University
Zhejiang Sheng, China
Patent: 7
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 6
Third Military Medical University
Chongqing Shi, China
Patent: 6
Fujian Sheng, China
Patent: 5